Healthcare Access
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Gain critical insights into global pharmaceutical market access, pricing, reimbursement, and policy shifts impacting drug launches and patient affordability.
Showing 1–5 of 5 articles
Pharmalittle: Roche accuses U.S. of 'blackmail,' Supreme Court rules on skinny labels
Roche's chairman calls U.S. drug pricing policy 'blackmail,' while the Supreme Court issues a ruling on skinny labels. This article breaks down what changed, who is affected, and what to watch next.
Opinion: The Virtual End of the Doctor's Office Waiting Room
The traditional doctor's office waiting room may soon be a relic of the past, replaced by innovative virtual waiting room solutions. These digital queues are not only improving patient experience but also streamlining healthcare operations.
OhioHealth and Fairfield Medical Center Terminate Merger Plans
OhioHealth and Fairfield Medical Center have officially terminated their proposed merger plans, a development that alters the landscape of healthcare provider news in Ohio. The initial announcement of the acquisition proposal was made last November.
Eli Lilly's 340B Data Mandate: A New Tactic in Pharma's Discount Program Battle
Eli Lilly has issued a five-day ultimatum to over 1,000 hospitals, requiring them to submit claims data or risk losing access to 340B drug discounts. This move signals a significant escalation in the ongoing conflict between pharmaceutical manufacturers and healthcare providers over the controversial program.
CMS and FDA Launch RAPID Coverage Pathway for Breakthrough Medical Devices Under Medicare
CMS and FDA announce RAPID coverage pathway to accelerate Medicare access to breakthrough medical devices, reducing coverage review delays for patients.